Press Releases Edesa Biotech, Inc.

Equities

EDSA

CA27966L3065

Market Closed - Nasdaq Other stock markets 21:30:00 15/05/2024 BST			5-day change	1st Jan Change
4.51 ^USD	-0.44%		-0.88%	-1.31%

05-10	Edesa Biotech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	CI
03-05	Top Premarket Gainers	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Edesa Biotech to Participate in Bloom Burton Healthcare Investor Conference	04-12	AQ
Edesa Biotech to Participate in Barclays Global Healthcare Conference	03-08	AQ
Regulators Approve Updated Phase 3 Trial Design for Edesa Biotech's ARDS Drug	26/10/23	AQ
Edesa Biotech Publishes Phase 2 Substudy Results of ARDS Drug Candidate	29/09/23	AQ
Edesa Biotech to Participate in Swiss Biotech Day	21/04/23	AQ
Edesa Biotech - The WHO and USAN Adopt Generic Name for Edesa's ARDS Drug Candidate	05/04/23	AQ
EDESA BIOTECH, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	27/03/23	AQ
EDESA BIOTECH, INC. : Regulation FD Disclosure (form 8-K)	13/03/23	AQ
Edesa Biotech Reports Fiscal 1st Quarter 2023 Results	13/02/23	AQ
EDESA BIOTECH, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	10/02/23	AQ
Edesa Biotech Reports Topline Phase 2b Results for Dermatology Drug	18/01/23	AQ
Edesa Biotech Reports Fiscal Year 2022 Results	19/12/22	AQ
EDESA BIOTECH, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-K)	16/12/22	AQ
Edesa Biotech to Participate in the 2022 Cantor Fitzgerald Dermatology Conference	05/12/22	AQ
EDESA BIOTECH, INC. : Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	03/11/22	AQ
Edesa Biotech Reports Statistically Significant Mortality Reductions in Phase 2 ARDS Drug Study	03/10/22	AQ
Edesa Biotech : Reports Fiscal 3rd Quarter 2022 Results - Form 8-K	12/08/22	PU
EDESA BIOTECH, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	12/08/22	AQ
Edesa Biotech to Participate at the Upcoming BTIG Biotech Conference	04/08/22	AQ
Edesa Biotech to Present at ARDS Drug Development Summit	12/07/22	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Edesa Biotech, Inc.

Equities

EDSA

CA27966L3065

Press Releases

Filters